Annual Retained Earnings:
-$3.96B-$569.18M(-16.80%)Summary
- As of today, RARE annual retained earnings is -$3.96 billion, with the most recent change of -$569.18 million (-16.80%) on December 31, 2024.
- During the last 3 years, RARE annual retained earnings has fallen by -$1.88 billion (-90.82%).
- RARE annual retained earnings is now -48420.47% below its all-time high of -$8.15 million, reached on December 31, 2011.
Performance
RARE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Retained Earnings:
-$4.22B-$114.95M(-2.80%)Summary
- As of today, RARE quarterly retained earnings is -$4.22 billion, with the most recent change of -$114.95 million (-2.80%) on June 30, 2025.
- Over the past year, RARE quarterly retained earnings has dropped by -$532.93 million (-14.44%).
- RARE quarterly retained earnings is now -15506.75% below its all-time high of -$27.06 million, reached on December 31, 2012.
Performance
RARE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RARE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -16.8% | -14.4% |
| 3Y3 Years | -90.8% | -77.1% |
| 5Y5 Years | -176.1% | -176.6% |
RARE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -90.8% | at low | -60.6% | at low |
| 5Y | 5-Year | -176.1% | at low | -164.7% | at low |
| All-Time | All-Time | >-9999.0% | at low | >-9999.0% | at low |
RARE Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -$4.22B(-2.8%) |
| Mar 2025 | - | -$4.11B(-3.8%) |
| Dec 2024 | -$3.96B(-16.8%) | -$3.96B(-3.5%) |
| Sep 2024 | - | -$3.82B(-3.6%) |
| Jun 2024 | - | -$3.69B(-3.7%) |
| Mar 2024 | - | -$3.56B(-5.0%) |
| Dec 2023 | -$3.39B(-21.8%) | -$3.39B(-3.8%) |
| Sep 2023 | - | -$3.26B(-5.1%) |
| Jun 2023 | - | -$3.10B(-5.4%) |
| Mar 2023 | - | -$2.94B(-5.9%) |
| Dec 2022 | -$2.78B(-34.1%) | -$2.78B(-5.8%) |
| Sep 2022 | - | -$2.63B(-10.3%) |
| Jun 2022 | - | -$2.38B(-7.1%) |
| Mar 2022 | - | -$2.23B(-7.3%) |
| Dec 2021 | -$2.07B(-28.0%) | -$2.07B(-6.3%) |
| Sep 2021 | - | -$1.95B(-3.9%) |
| Jun 2021 | - | -$1.88B(-7.0%) |
| Mar 2021 | - | -$1.76B(-8.4%) |
| Dec 2020 | -$1.62B(-13.0%) | -$1.62B(-1.5%) |
| Sep 2020 | - | -$1.60B(-4.5%) |
| Jun 2020 | - | -$1.53B(+1.6%) |
| Mar 2020 | - | -$1.55B(-8.3%) |
| Dec 2019 | -$1.43B | -$1.43B(-7.0%) |
| Sep 2019 | - | -$1.34B(-9.2%) |
| Jun 2019 | - | -$1.23B(-8.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$1.13B(-9.4%) |
| Dec 2018 | -$1.03B(-23.7%) | -$1.03B(-9.3%) |
| Sep 2018 | - | -$942.46M(-10.2%) |
| Jun 2018 | - | -$855.15M(-6.6%) |
| Mar 2018 | - | -$802.42M(+3.6%) |
| Dec 2017 | -$832.67M(-57.0%) | -$832.67M(-10.9%) |
| Sep 2017 | - | -$750.94M(-11.8%) |
| Jun 2017 | - | -$671.71M(-12.2%) |
| Mar 2017 | - | -$598.82M(-12.9%) |
| Dec 2016 | -$530.53M(-86.4%) | -$530.53M(-15.5%) |
| Sep 2016 | - | -$459.25M(-16.5%) |
| Jun 2016 | - | -$394.34M(-16.9%) |
| Mar 2016 | - | -$337.42M(-18.5%) |
| Dec 2015 | -$284.66M(-104.7%) | -$284.66M(-24.1%) |
| Sep 2015 | - | -$229.44M(-20.6%) |
| Jun 2015 | - | -$190.21M(-18.6%) |
| Mar 2015 | - | -$160.42M(-15.4%) |
| Dec 2014 | -$139.04M(-85.8%) | -$139.04M(-13.7%) |
| Sep 2014 | - | -$122.30M(-14.9%) |
| Jun 2014 | - | -$106.45M(-14.6%) |
| Mar 2014 | - | -$92.87M(-24.1%) |
| Dec 2013 | -$74.84M(-176.6%) | -$74.84M(-31.6%) |
| Sep 2013 | - | -$56.85M(-26.8%) |
| Jun 2013 | - | -$44.83M(-65.7%) |
| Dec 2012 | -$27.06M(-231.8%) | -$27.06M |
| Dec 2011 | -$8.15M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual retained earnings?
- What is the all-time high annual retained earnings for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual retained earnings year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings?
- What is the all-time high quarterly retained earnings for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual retained earnings?
The current annual retained earnings of RARE is -$3.96B
What is the all-time high annual retained earnings for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual retained earnings is -$8.15M
What is Ultragenyx Pharmaceutical Inc. annual retained earnings year-on-year change?
Over the past year, RARE annual retained earnings has changed by -$569.18M (-16.80%)
What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings?
The current quarterly retained earnings of RARE is -$4.22B
What is the all-time high quarterly retained earnings for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly retained earnings is -$27.06M
What is Ultragenyx Pharmaceutical Inc. quarterly retained earnings year-on-year change?
Over the past year, RARE quarterly retained earnings has changed by -$532.93M (-14.44%)